AXIM
AXIM BIOTECHNOLOGIES INC
stock OTC

axim biotechnologies, inc. is a vertically integrated research and development company focused on changing diagnosis and treatment for oncology and sars-cov-2 (covid-19). the company's neucovix is the rapid diagnostic test measuring levels of functional neutralizing antibodies that are believed to prevent sars-cov-2 from entering the host cells. it is developing rapid diagnostic tests for the early detection of cancer and proprietary small molecules drugs to treat cancer and block metastasis. the company was formerly known as axim international inc. and changed its name to axim biotechnologies, inc. in july 2014. axim biotechnologies, inc. was founded in 2010 and is headquartered in san diego, california.